总时间（秒）：30.63
问答时间（秒）：28.31

<think>
Okay, let's tackle this query. The user wants me to extract information from a scientific paper about LRRK2 mutations and Parkinson's disease. They provided a detailed JSON structure, so I need to make sure I follow that exactly.

First, I'll start with the variants. The paper mentions several PD mutations: G2019S, R1941H, I2012T, I2020T, G2385R, R1441C, R1441G, Y1699C, and T2356I. I need to standardize their HGVS nomenclature. But wait, the paper doesn't give specific transcript IDs or cDNA changes. Hmm, the user mentioned using APIs for standardization, but without the transcript info, I can't generate the exact HGVS. Maybe the paper just refers to the protein changes? Let me check the text again.

Looking at the abstract, it says "nine previously reported PD mutations of LRRK2" but doesn't specify the exact cDNA changes. So, for the HGVS, I might have to use the protein change, but the user's example shows cDNA. Since the paper doesn't provide transcript numbers, I should use N.D. for the transcript and position. But the user's example includes the transcript, so maybe they expect me to find that elsewhere? Wait, the user might not have the transcript info, so I should use N.D. where necessary.

Next, the disease is Parkinson's disease. I need the MONDO term. MONDO:0005335 is the correct term for Parkinson's disease. Got that.

For the experimental methods, the paper describes a KESTREL screen in rat brain extracts. The readout is phosphorylation of moesin, ezrin, and radixin. The variants' effects are categorized as stimulating, no effect, or inhibiting. The paper mentions that G2019S stimulated, others had no effect or inhibited. So, each variant's conclusion would be Abnormal or Normal based on their effect. Molecular effects could be gain-of-function for G2019S, and others as no effect or loss-of-function. But the paper doesn't specify, so maybe N.D. for some.

Biological and technical replicates: The paper doesn't mention replicates explicitly, so I'll put N.D. for those. Controls: The KESTREL screen might have used wild-type as a control, but again, not specified. So N.D. for controls. Statistical analysis isn't mentioned, so N.D. there too. Thresholds for normal and abnormal readouts aren't provided, so I'll use the user's instructions to use custom if not in the literature. Approved assay: Since the method is a kinase assay, which is commonly used for studying kinase activity, I'll say Yes.

Putting it all together, making sure each section is filled with the info from the paper or N.D. where not present. Check for any missing parts and ensure the JSON structure is correct.
</think>

{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "G2019S, R1941H, I2012T, I2020T, G2385R, R1441C, R1441G, Y1699C, T2356I"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005335"
  },
  "Experiment Method": [
    {
      "Assay Method": "KESTREL screen (kinase activity assay)",
      "Material used": {
        "Material Source": "N.D.",
        "Material Name": "Rat brain extracts",
        "Description": "KESTREL screen was performed in rat brain extracts to assess kinase activity of LRRK2 mutants."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "G2019S mutation in LRRK2 stimulated phosphorylation of moesin, ezrin, and radixin in the KESTREL screen."
        },
        {
          "Variant": "N.D.",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "Mutations R1941H, I2012T, I2020T, G2385R, R1441C, R1441G, Y1699C, and T2356I showed no significant effect on phosphorylation of moesin, ezrin, and radixin."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No significant deviation from baseline phosphorylation levels.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels exceeding 20% of baseline in the KESTREL screen.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}